- Home
- STAG vs IONS Comparison
STAG vs IONS Comparison
Compare STAG & IONS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAG
- IONS
- Stock Information
- Founded
- STAG 2010
- IONS 1989
- Country
- STAG United States
- IONS United States
- Employees
- STAG N/A
- IONS N/A
- Industry
- STAG Real Estate Investment Trusts
- IONS Biotechnology: Pharmaceutical Preparations
- Sector
- STAG Real Estate
- IONS Health Care
- Exchange
- STAG Nasdaq
- IONS Nasdaq
- Market Cap
- STAG 6.7B
- IONS 6.8B
- IPO Year
- STAG 2011
- IONS 1991
- Fundamental
- Price
- STAG $36.28
- IONS $63.16
- Analyst Decision
- STAG Buy
- IONS Buy
- Analyst Count
- STAG 7
- IONS 17
- Target Price
- STAG $37.86
- IONS $67.88
- AVG Volume (30 Days)
- STAG 1.1M
- IONS 3.3M
- Earning Date
- STAG 10-28-2025
- IONS 11-05-2025
- Dividend Yield
- STAG 4.10%
- IONS N/A
- EPS Growth
- STAG 22.47
- IONS N/A
- EPS
- STAG 1.27
- IONS N/A
- Revenue
- STAG $803,231,000.00
- IONS $944,050,000.00
- Revenue This Year
- STAG $11.18
- IONS $24.30
- Revenue Next Year
- STAG $7.30
- IONS $7.39
- P/E Ratio
- STAG $28.65
- IONS N/A
- Revenue Growth
- STAG 8.56
- IONS 16.05
- 52 Week Low
- STAG $28.61
- IONS $23.95
- 52 Week High
- STAG $40.40
- IONS $64.72
- Technical
- Relative Strength Index (RSI)
- STAG 52.05
- IONS 79.95
- Support Level
- STAG $35.72
- IONS $62.79
- Resistance Level
- STAG $36.52
- IONS $64.72
- Average True Range (ATR)
- STAG 0.55
- IONS 2.29
- MACD
- STAG -0.05
- IONS 1.49
- Stochastic Oscillator
- STAG 29.95
- IONS 93.22
About STAG Stag Industrial Inc.
Stag Industrial Inc is a real estate investment trust that is involved in the acquisition and operation of both single- and multi-tenant properties, although the majority of the portfolio is single-tenant industrial properties throughout the United States. The vast majority of the company's real estate portfolio is comprised of warehouse and distribution buildings. Stag Industrial derives nearly all of its income in the form of rental income from its portfolio of warehouse and distribution properties. The company generates the majority of its rental revenue from its facilities located in Midwestern and Eastern U.S. cities. Stag Industrial's customers include air freight and logistics, automotive, and industrial equipment companies in terms of overall revenue.
About IONS Ionis Pharmaceuticals Inc.
Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.